Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmgate Animal Health is a global animal health company that specializes in the development, manufacture, and marketing of medicated feed additives and biologicals for livestock, particularly swine and poultry. As a joint venture with Jinhe Biotechnology, the world's largest producer of chlortetracycline, Pharmgate is vertically integrated, ensuring a consistent and high-quality supply of essential veterinary medicines. The company's portfolio includes the innovative Gard line of vaccines, which target major swine pathogens like PCV2 and Mycoplasma, alongside a robust range of antimicrobial products such as Pennchlor and Pennox. With manufacturing facilities in the United States and Canada, Pharmgate provides comprehensive health solutions to veterinarians and producers across North America and international markets. The company is headquartered in Wilmington, North Carolina, and is recognized for its commitment to technical support and product efficacy in the animal protein production sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmgate Animal Health.